<p>The changes in VWF parameters normalized to baseline are displayed longitudinally over pregnancy for time points sampled in pre-pregnancy n = 14, 1<sup>st</sup> trimester n = 24, 2<sup>nd</sup> trimester n = 38, 3<sup>rd</sup> trimester n = 44, 38wks n = 12, and postpartum n = 41. Asterisks (*) indicate <i>p</i><0.05 compared to postpartum values (one-way ANOVA, all pairwise multiple comparisons). Standard deviations, means, 25<sup>th</sup>, and 75<sup>th</sup> percentiles are omitted for clarity and can be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0112935#pone-0112935-t004" target="_blank">Table 4</a>.</p
Antepartum to postpartum trends in (A) EQ-5D-5L Index, (B) EQ-5D-5L VAS, and (C) MFI. All data are p...
Objectives: To assess and correlate changes in body composition and haemodynamic function during pre...
Purpose: The aim of this study was to assess longitudinal changes of bioimpedance analysis compared ...
<p><u>Sample numbers (n):</u> Pre-pregnancy (14), 1<sup>st</sup> trimester (24), 2<sup>nd</sup> trim...
<p><u>Trimesters (n):</u> 1st trimester (24), 2nd trimester (38), 3rd trimester (46), Non-pregnant b...
<p>Values for VWF:Ag (<b>A</b>), FVIII (<b>B</b>), VWFpp (<b>C</b>), FVIII:VWF Ratio (<b>D</b>), VWF...
<p>A normalized 1% multimer gel (<b>A</b>) and densitometry (<b>B</b>) of plasma VWF multimers from ...
<p>A normalized high resolution 2.6% multimer gel (<b>A</b>) and densitometry (<b>B</b>) of the same...
<p>The * indicates significance in the VDBP concentration in gestational groups ≤30–31 weeks' compar...
Background: The coagulation protein von Willebrand Factor (VWF) is known to be elevated in pregnancy...
<p>VDBP was not significantly different between singleton and twin gestation in-labour (<i>P</i> = 1...
<p>The * indicates a significant difference in VDBP concentration in the CVF between the in-labour g...
a<p>p<.0001, <sup>b</sup>p<.05.</p><p><i>*residual errors were allowed to vary over time and were si...
<p>Median and 25<sup>th</sup>−75<sup>th</sup> percentile for sEng levels at presentation stratified ...
Background: Parity is associated with increased maternal risk of cardiovascular disease (CVD) in a J...
Antepartum to postpartum trends in (A) EQ-5D-5L Index, (B) EQ-5D-5L VAS, and (C) MFI. All data are p...
Objectives: To assess and correlate changes in body composition and haemodynamic function during pre...
Purpose: The aim of this study was to assess longitudinal changes of bioimpedance analysis compared ...
<p><u>Sample numbers (n):</u> Pre-pregnancy (14), 1<sup>st</sup> trimester (24), 2<sup>nd</sup> trim...
<p><u>Trimesters (n):</u> 1st trimester (24), 2nd trimester (38), 3rd trimester (46), Non-pregnant b...
<p>Values for VWF:Ag (<b>A</b>), FVIII (<b>B</b>), VWFpp (<b>C</b>), FVIII:VWF Ratio (<b>D</b>), VWF...
<p>A normalized 1% multimer gel (<b>A</b>) and densitometry (<b>B</b>) of plasma VWF multimers from ...
<p>A normalized high resolution 2.6% multimer gel (<b>A</b>) and densitometry (<b>B</b>) of the same...
<p>The * indicates significance in the VDBP concentration in gestational groups ≤30–31 weeks' compar...
Background: The coagulation protein von Willebrand Factor (VWF) is known to be elevated in pregnancy...
<p>VDBP was not significantly different between singleton and twin gestation in-labour (<i>P</i> = 1...
<p>The * indicates a significant difference in VDBP concentration in the CVF between the in-labour g...
a<p>p<.0001, <sup>b</sup>p<.05.</p><p><i>*residual errors were allowed to vary over time and were si...
<p>Median and 25<sup>th</sup>−75<sup>th</sup> percentile for sEng levels at presentation stratified ...
Background: Parity is associated with increased maternal risk of cardiovascular disease (CVD) in a J...
Antepartum to postpartum trends in (A) EQ-5D-5L Index, (B) EQ-5D-5L VAS, and (C) MFI. All data are p...
Objectives: To assess and correlate changes in body composition and haemodynamic function during pre...
Purpose: The aim of this study was to assess longitudinal changes of bioimpedance analysis compared ...